290 related articles for article (PubMed ID: 2244292)
1. Aminoglycosides: assessing the potential for nephrotoxicity.
Wilson SE
Surg Gynecol Obstet; 1990; 171 Suppl():24-30. PubMed ID: 2244292
[TBL] [Abstract][Full Text] [Related]
2. Aminoglycoside nephrotoxicity: keys to prevention.
Levin ML
J Crit Illn; 1994 Oct; 9(10):911-2, 915. PubMed ID: 10150695
[TBL] [Abstract][Full Text] [Related]
3. [Is it possible to reduce the incidence of aminoglycoside-induced nephrotoxicity?].
Fillastre JP
Bull Acad Natl Med; 1999; 183(5):973-82; discussion 983. PubMed ID: 10465001
[TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
Rankin GO; Sutherland CH
Adverse Drug React Acute Poisoning Rev; 1989; 8(2):73-88. PubMed ID: 2672726
[TBL] [Abstract][Full Text] [Related]
5. Risk of nephrotoxicity with combination vancomycin-aminoglycoside antibiotic therapy.
Pauly DJ; Musa DM; Lestico MR; Lindstrom MJ; Hetsko CM
Pharmacotherapy; 1990; 10(6):378-82. PubMed ID: 2287556
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside-induced vestibular injury: maintaining a sense of balance.
Ariano RE; Zelenitsky SA; Kassum DA
Ann Pharmacother; 2008 Sep; 42(9):1282-9. PubMed ID: 18648019
[TBL] [Abstract][Full Text] [Related]
7. [Aminoglycoside-induced nephrotoxicity].
Fabrizii V; Thalhammer F; Hörl WH
Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
[TBL] [Abstract][Full Text] [Related]
8. Glomerular nephrotoxicity of aminoglycosides.
Martínez-Salgado C; López-Hernández FJ; López-Novoa JM
Toxicol Appl Pharmacol; 2007 Aug; 223(1):86-98. PubMed ID: 17602717
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine.
Tzovaras V; Tsimihodimos V; Kostara C; Mitrogianni Z; Elisaf M
Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252
[TBL] [Abstract][Full Text] [Related]
10. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
Graham AC; Mercier RC; Achusim LE; Pai MP
Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and nephrotoxicity of aminoglycoside antibiotics].
Marino A; Pisanti N
Clin Ter; 1989 Jun; 129(6):421-8. PubMed ID: 2526703
[TBL] [Abstract][Full Text] [Related]
12. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.
de Jager P; van Altena R
Int J Tuberc Lung Dis; 2002 Jul; 6(7):622-7. PubMed ID: 12102302
[TBL] [Abstract][Full Text] [Related]
13. Controversies in antimicrobial therapy: pitfalls in monitoring aminoglycoside therapy.
Fant WK
Am J Hosp Pharm; 1986 Mar; 43(3):641-6. PubMed ID: 3706319
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside induced ototoxicity.
Guthrie OW
Toxicology; 2008 Jul; 249(2-3):91-6. PubMed ID: 18514377
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
Kim J; Lee KH; Yoo S; Pai H
Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
[TBL] [Abstract][Full Text] [Related]
16. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
Whelton A
Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
[TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside nephrotoxicity: pathogenesis and prevention.
Cronin RE
Clin Nephrol; 1979 May; 11(5):251-6. PubMed ID: 378495
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the incidence of nephrotoxicity associated with the use of aminoglycosides in patients with extrahepatic biliary obstruction].
Márquez E; Lucena MI; Andrade RJ; González-Correa JA; Clavijo E; Lazo MD; Sánchez de la Cuesta F
Rev Clin Esp; 1992 Jun; 191(2):76-9. PubMed ID: 1502393
[TBL] [Abstract][Full Text] [Related]
19. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
[TBL] [Abstract][Full Text] [Related]
20. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
